http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PL-426472-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7ca8cae3c3e47c259141d55deec37c34
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0063
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-185
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-14
filingDate 2018-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9dae1fefc1c1f48676e4af57270eeb7e
publicationDate 2020-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber PL-426472-A1
titleOfInvention Medical use of domiphen bromide and a composition for treating inflammation in the oral cavity
abstract The subject of the application is domiphen bromide and a pharmaceutical composition containing domiphen bromide and pharmaceutically acceptable excipients. The composition is characterized in that 100 ml of the solution contains: domiphen bromide in an amount of 0.01-0.10%, preferably 0.01-0.03%; - purified water from 90 to 99.9%; - mineral salts (buffering, isotonic), preferably NaCl, KCl, CaCl2, MgCl2, NaH2PO4, KH2PO4, Na2HPO4, K2HPO4, Na2CO3, NaHCO3, in an amount from 0.5 to 5.0%, preferably 0.5-1 5%; and optionally flavors, preferably mint, apple, anise, lime, lemon, raspberry, cinnamon, clove in an amount of 0.1 to 0.9%.
priorityDate 2018-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10866
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449122806
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID2708
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454620584
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559212
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453569306
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447574277
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452899714
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5360315
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23672064
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451474997
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24450
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID219868
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID128608
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID516951
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447917096
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448098817
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID259
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10340
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID40880
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID128608
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID2708
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID219868
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21225616
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID40880
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID516892
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453034310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID190226
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4873
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID190226
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234

Total number of triples: 52.